Cover Image
市場調查報告書

大便潛血試驗的全球市場:2016∼2020年

Global Fecal Occult Testing market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 369205
出版日期 內容資訊 英文 89 Pages
訂單完成後即時交付
價格
Back to Top
大便潛血試驗的全球市場:2016∼2020年 Global Fecal Occult Testing market 2016-2020
出版日期: 2016年09月01日 內容資訊: 英文 89 Pages
簡介

大便潛血試驗是非侵入性的簡單檢驗,受許多醫生喜好。結果可即時得到POC檢測套組。全球大便潛血試驗市場預計2016∼2020年以4.82%的年複合成長率擴大。

本報告提供全球大便潛血試驗市場相關調查,市場的各產品,各終端用戶,各地區趨勢,今後的成長預測,以及加入此市場的主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 大便潛血試驗的全球市場:各產品市場區隔

  • FIT
  • 愈創樹脂肪檢驗
  • 航班DNA檢驗

第7章 大便潛血試驗的全球市場:各終端用戶市場區隔

  • 醫院
  • 臨床診斷測試所
  • 診療所實驗室

第8章 大便潛血試驗的全球市場:各地區市場區隔

  • 歐洲、中東、非洲
  • 南北美洲
  • 亞太地區

第9章 大便潛血試驗的全球市場:促進要素

  • 高齡化
  • 全世界的政府的配合措施和試驗計劃
  • 家庭使用的患者中心模式的動機

第10章 促進要素的影響

第11章 大便潛血試驗的全球市場:課題

  • FIT的成本高與有限的償付
  • 診斷的不正確
  • 認識不足和醫生不勸大便潛血試驗的事

第12章 促進要素與課題的影響

第13章 大便潛血試驗的全球市場:趨勢

第14章 供應商環境

  • 競爭模式

第15章 主要供應商

  • Geographical presence: Major vendors
  • Beckman Coulter
  • Eiken Chemical
  • Epigenomics
  • Quidel
  • 主要消息
  • 其他值得注意的供應商

第16章 附錄

第17章 關於Technavio

目錄
Product Code: IRTNTR10367

About Fecal Occult Testing

Fecal occult testing is simple and non-invasive in nature, thereby increasing its preference among many physicians. The results of few of the fecal occult tests can be obtained rapidly through point-of-care (POC) test kits such as Alere's Clearview iFOB, and Beckman Coulter's Hemoccult II SENSA. For instance, the Clearview iFOB test is based on human hemoglobin and gastrointestinal bleeding, and can provide results in five minutes. Beckman Coulter's Hemoccult II SENSA slides allow people to collect fecal samples at home settings and send them to hospitals, laboratories, and diagnostic centers.

Technavio's analysts forecast the global fecal occult testing market to grow at a CAGR of 4.82% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global fecal occult testing market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of fecal occult testing products used to perform colorectal cancer screening.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Fecal Occult Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Beckman Coulter
  • Eiken Chemical
  • Epigenomics
  • Quidel

Other Prominent Vendors

  • Abbott Laboratories
  • AccuBioTech
  • Applied Proteomics
  • ASAN PHARM.
  • Assure Tech.
  • BIOHIT Healthcare
  • EDP Biotech
  • FUJIREBIO
  • GeneNews
  • NanoRepro
  • Nantong Egens Biotechnology
  • Orion Diagnostica
  • Polymedco
  • Quest Diagnostics
  • Randox
  • VolitionRx

Market driver

  • Government initiatives and pilot programs worldwide
  • For a full, detailed list, view our report

Market challenge

  • High cost of FITs and limited reimbursement
  • For a full, detailed list, view our report

Market trend

  • Direct-to-consumer laboratory testing
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market Overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

  • Global fecal occult testing market by FIT
  • Global fecal occult testing market by guaiac test
  • Global fecal occult testing market by stool DNA test

PART 07: Market segmentation by end-user

  • Global fecal occult testing market by hospitals
  • Global fecal occult testing market by clinical diagnostic laboratories
  • Global fecal occult testing market by physicians' office laboratories

PART 08: Geographical segmentation

  • Fecal occult testing market in Americas
  • Fecal occult testing market in EMEA
  • Fecal occult testing market in APAC

PART 09: Market drivers

  • Rise in geriatric population
  • Government initiatives and pilot programs worldwide
  • Shift toward patient-centered model (POC FITs) for home use

PART 10: Impact of drivers

PART 11: Market challenges

  • High cost of FITs and limited reimbursement
  • Inaccuracies in diagnosis
  • Limited awareness and reluctance of physicians to recommend fecal occult testing

PART 12: Impact of drivers and challenges

PART 13: Market trends

  • Collaboration between research centers and manufacturers
  • Online marketing of fecal occult immunological test devices
  • Direct-to-consumer laboratory testing

PART 14: Vendor landscape

  • Competitive scenario

PART 15: Key vendor analysis

  • Geographical presence: Major vendors
  • Beckman Coulter
  • Eiken Chemical
  • Epigenomics
  • Quidel
  • Key news
  • Other prominent vendors

PART 16: Appendix

  • List of abbreviations

PART 17: Explore Technavio

List of Exhibits

  • Exhibit 01: Global fecal occult testing market: Three significant estimations
  • Exhibit 02: Product offerings
  • Exhibit 03: Colorectal cancer screening tests: Advantages and disadvantages of fecal occult testing
  • Exhibit 04: Scale of colorectal cancer cases in UK
  • Exhibit 05: Adoption of Cologuard in US 2014-2015
  • Exhibit 06: Segmentation of global fecal occult testing market
  • Exhibit 07: Global fecal occult testing market: Impact assessment
  • Exhibit 08: Global fecal occult testing market 2015-2020 ($ millions)
  • Exhibit 09: New cases and deaths related to colorectal cancer per 100,000 people in US 2004-2014
  • Exhibit 10: Government guidelines and support in some developed countries
  • Exhibit 11: Five forces analysis
  • Exhibit 12: Global fecal occult testing market by product 2015 and 2020
  • Exhibit 13: Global fecal occult testing market by FIT: An overview
  • Exhibit 14: Global fecal occult testing market by FIT 2015-2020 ($ millions)
  • Exhibit 15: Comparison of FIT and guaiac test
  • Exhibit 16: Global fecal occult testing market by guaiac test: An overview
  • Exhibit 17: Global fecal occult testing market by guaiac test 2015-2020 ($ millions)
  • Exhibit 18: Global fecal occult testing market by stool DNA test: An overview
  • Exhibit 19: Global fecal occult testing market by stool DNA test 2015-2020 ($ millions)
  • Exhibit 20: Global fecal occult testing market segmentation by end-user 2015
  • Exhibit 21: Revenue generated by diagnostic and medical laboratories in US 2009-2014
  • Exhibit 22: Global fecal occult testing market segmentation by geography 2015 and 2020
  • Exhibit 23: Fecal occult testing market in Americas: An overview
  • Exhibit 24: Fecal occult testing market in Americas 2015-2020 ($ millions)
  • Exhibit 25: Fecal occult testing market in Americas: Metrics analysis for various countries 2015 and 2020
  • Exhibit 26: Fecal occult testing market in US: Key takeaways
  • Exhibit 27: Fecal occult testing market in EMEA: An overview
  • Exhibit 28: Colorectal cancer mortality per 100,000 individuals in European countries 2003 and 2013
  • Exhibit 29: Fecal occult testing market in EMEA 2015-2020 ($ millions)
  • Exhibit 30: Fecal occult testing market in EMEA: Metrics analysis of various countries 2015 and 2020
  • Exhibit 31: Fecal occult testing market in UK: Key takeaways
  • Exhibit 32: Fecal occult testing market in APAC: An overview
  • Exhibit 33: Colorectal cancer mortality per 100,000 individuals in APAC 2003 and 2013
  • Exhibit 34: Fecal occult testing market in APAC 2015-2020 ($ millions)
  • Exhibit 35: Fecal occult testing market in APAC: Metrics analysis for various countries 2015 and 2020
  • Exhibit 36: People in age group 60 years and above worldwide 2010-2050
  • Exhibit 37: Government initiatives for colorectal cancer and fecal occult testing in some countries
  • Exhibit 38: Some POC FITs available in market
  • Exhibit 39: Impact of drivers
  • Exhibit 40: Study results: Potential barriers affecting adoption of FOBTs
  • Exhibit 41: Impact of drivers and challenges
  • Exhibit 42: Some collaborations and their impact
  • Exhibit 43: Some companies and their distribution partners
  • Exhibit 44: Global fecal occult testing market: Competitive structure analysis 2015
  • Exhibit 45: Global fecal occult testing market: Competitive landscape analysis
  • Exhibit 46: Market penetration of vendors of fecal occult testing kits 2015
  • Exhibit 47: Global fecal occult testing market: Strategic success factors of companies
  • Exhibit 48: Major vendors: Regional analysis
  • Exhibit 49: Beckman Coulter: Profile summary
  • Exhibit 50: Beckman Coulter: Strength analysis
  • Exhibit 51: Beckman Coulter: Growth strategy matrix
  • Exhibit 52: Beckman Coulter: Opportunity assessment
  • Exhibit 53: Eiken Chemical: Profile summary
  • Exhibit 54: Eiken Chemical: Strength analysis
  • Exhibit 55: Eiken Chemical: Growth strategy matrix
  • Exhibit 56: Eiken Chemical: Opportunity assessment
  • Exhibit 57: Epigenomics: Profile summary
  • Exhibit 58: Epigenomics: Strength analysis
  • Exhibit 59: Epigenomics: Growth strategy matrix
  • Exhibit 60: Epigenomics: Opportunity assessment
  • Exhibit 61: Quidel: Profile summary
  • Exhibit 62: Quidel: Strength analysis
  • Exhibit 63: Quidel: Growth strategy matrix
  • Exhibit 64: Quidel: Opportunity assessment
  • Exhibit 65: Other prominent vendors
Back to Top